Literature DB >> 8248537

Cholinergic systems: human diseases, animal models, and prospects for therapy.

D L Price1, V E Koliatsos, R C Clatterbuck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8248537     DOI： 10.1016/s0079-6123(08)62380-8

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN： 0079-6123            Impact factor:   2.453


× No keyword cloud information.
  6 in total

1.  Voltage-dependent neuromodulation of Na+ channels by D1-like dopamine receptors in rat hippocampal neurons.

Authors:  A R Cantrell; T Scheuer; W A Catterall
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

Review 2.  Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease.

Authors:  Farida Sohrabji
Journal:  Gene Expr       Date:  2007

3.  Reduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in mice.

Authors:  Daniel J Payette; Jun Xie; Qing Guo
Journal:  Brain Res       Date:  2006-12-29       Impact factor: 3.252

4.  5-Aryl-1,3,4-oxadiazol-2-amines Decorated with Long Alkyl and Their Analogues: Synthesis, Acetyl- and Butyrylcholinesterase Inhibition and Docking Study.

Authors:  Václav Pflégr; Šárka Štěpánková; Katarína Svrčková; Markéta Švarcová; Jarmila Vinšová; Martin Krátký
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-25

5.  Genetically-directed, cell type-specific sparse labeling for the analysis of neuronal morphology.

Authors:  Thomas Rotolo; Philip M Smallwood; John Williams; Jeremy Nathans
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

6.  Improvements in memory after medial septum stimulation are associated with changes in hippocampal cholinergic activity and neurogenesis.

Authors:  Da Un Jeong; Ji Eun Lee; Sung Eun Lee; Won Seok Chang; Sung June Kim; Jin Woo Chang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.